Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for sensory nerve conduction threshold tests (sNCTs), effective May 15, 2026. Here's what billing teams need to do.
CMS sensory nerve conduction threshold test coverage policy has a history of controversy, and this 2026 update continues that tradition. The Centers for Medicare & Medicaid Services has long treated sNCTs with skepticism — classifying them as non-covered in most contexts because the clinical evidence hasn't met Medicare's medical necessity bar. This modification reinforces and clarifies that position. The policy does not list specific CPT or HCPCS codes in the data available for this update, but sNCT billing has historically centered on a narrow set of nerve conduction study codes, and your billing team needs to understand where CMS draws the line before the May 15, 2026 effective date.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Sensory Nerve Conduction Threshold Tests (sNCTs) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Neurology, Physical Medicine & Rehabilitation, Pain Management, Podiatry |
| Key Action | Audit all sNCT claims before May 15, 2026 and confirm your documentation supports medical necessity or stops billing for non-covered indications |
CMS Sensory Nerve Conduction Threshold Test Coverage Criteria and Medical Necessity Requirements 2026
This is where sNCT billing gets complicated — and where most denials originate.
CMS has consistently distinguished between conventional nerve conduction studies (NCS) and sensory nerve conduction threshold tests. Standard NCS measures the speed and amplitude of nerve signals. sNCTs, by contrast, measure the threshold at which a patient perceives a stimulus. That distinction matters enormously for coverage policy purposes.
CMS's position is that sNCTs do not meet medical necessity standards for Medicare reimbursement under most clinical scenarios. The agency has pointed to insufficient clinical evidence that sNCT results change patient management in a meaningful, documented way. That's the core issue: a test that doesn't demonstrably alter treatment decisions fails the Medicare medical necessity test, full stop.
Whether sNCTs are covered under Medicare depends heavily on how they're billed and what clinical justification appears in the record. If your practice has been billing sNCTs alongside conventional electrodiagnostic studies — assuming coverage flows from one to the other — this policy is a direct warning. It doesn't work that way.
The 2026 modification doesn't appear to break new ground in terms of reversing CMS's historical skepticism. What it does is update and clarify the agency's standing position, which means MACs (Medicare Administrative Contractors) now have fresh CMS-level authority to deny claims that don't align with the updated language. Regional MACs often issue Local Coverage Determinations (LCDs) that track CMS national guidance closely. After May 15, 2026, expect MAC auditors to apply stricter scrutiny to any sNCT claims in your queue.
Prior authorization for sNCTs isn't a universal Medicare requirement — but that doesn't mean you can skip the documentation step. CMS medical necessity requirements still apply, and a missing or thin clinical justification in the chart is a straight path to claim denial.
CMS Sensory Nerve Conduction Threshold Test Exclusions and Non-Covered Indications
CMS's long-standing concern with sNCTs is that they function more as research tools than clinical decision-making tools. That framing shapes every exclusion.
Screening use is not covered. If a provider orders an sNCT to screen for peripheral neuropathy in the absence of documented symptoms or a clinical indication, CMS will not reimburse it. Medicare is not a screening payer for tests it considers unproven at the population level.
Standalone sNCTs — billed without a conventional electrodiagnostic workup that supports the clinical picture — face near-certain denial. CMS expects sNCTs, when billed at all, to exist within a coherent diagnostic framework. A single-test visit built around an sNCT alone is a red flag for audit.
Repeated sNCTs for monitoring are also problematic. Some practices have used sNCT results to track disease progression in diabetic neuropathy or similar conditions. CMS does not accept serial sNCT monitoring as a covered service under its current coverage policy, because the evidence that serial results change clinical management isn't there.
If your practice is in pain management or podiatry, pay special attention here. Both specialties have seen sNCT use as an adjunct to neuropathy evaluation. The risk of claim denial in those settings is high if documentation doesn't clearly establish why a conventional NCS alone was insufficient.
Coverage Indications at a Glance
The policy data for this update does not include a formal indication-level breakdown with specific covered vs. non-covered designations. The table below reflects CMS's established coverage framework for sNCTs, derived from the agency's historical national guidance.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Screening for peripheral neuropathy (no documented symptoms) | Not Covered | Not specified in this update | Fails medical necessity; no coverage regardless of diagnosis |
| Standalone sNCT without concurrent conventional NCS | Not Covered | Not specified in this update | Insufficient clinical basis for standalone billing |
| Serial sNCT monitoring for disease progression | Not Covered | Not specified in this update | CMS does not accept as evidence-based management tool |
| sNCT as part of broader electrodiagnostic workup | Covered status unclear | Not specified in this update | Coverage varies by MAC LCD; document clinical necessity explicitly |
| Research or experimental protocols | Not Covered | Not specified in this update | Not a covered service under any Medicare pathway |
Note: This policy update does not list specific CPT or HCPCS codes. Check your MAC's LCD for code-level guidance that applies to your region.
CMS Sensory Nerve Conduction Threshold Test Billing Guidelines and Action Items 2026
The effective date of May 15, 2026 gives your team a hard deadline. Here's what to do before then.
| # | Action Item |
|---|---|
| 1 | Pull your sNCT claim history from the last 12 months. Look for any claims where sNCTs were billed without a concurrent conventional nerve conduction study. Those are your highest denial risk after the effective date. Quantify the exposure before you do anything else. |
| 2 | Cross-reference your MAC's LCD. CMS sets national direction, but your Medicare Administrative Contractor applies it at the regional level. Pull the current LCD covering nerve conduction studies in your jurisdiction. If your MAC hasn't updated its LCD to reflect this 2026 modification yet, it will. Don't wait — contact your MAC's provider outreach line if you need clarity on timing. |
| 3 | Audit your clinical documentation templates before May 15, 2026. If your providers use a standard template for electrodiagnostic studies, check whether it captures the specific clinical rationale for ordering an sNCT vs. a conventional NCS. Thin documentation is the #1 driver of claim denial on these services. Update the template now. |
| 4 | Train your ordering providers on the medical necessity standard. Your billing team can't fix a documentation problem they didn't create. The physician or NPP ordering the sNCT needs to document why the test was necessary, why a conventional NCS wasn't sufficient on its own, and how the results will change patient management. If that clinical rationale isn't in the chart, the claim won't hold up. |
| 5 | Review your charge capture for sNCT services. If your team has been billing sNCTs as a routine add-on to electrodiagnostic workups, stop. Each sNCT claim needs independent clinical justification. The days of bundling sNCTs into a standard nerve study visit without separate documentation are over. |
| 6 | Flag pending sNCT claims for review. Any claim in your accounts receivable queue that was submitted before May 15, 2026 but hasn't adjudicated yet may be reviewed under the new coverage policy language. Talk to your billing consultant about whether to hold, rework, or submit those claims with additional documentation. |
| 7 | If your practice volume of sNCTs is significant, loop in your compliance officer now. Retroactive audits are a real risk when CMS modifies a policy that has a history of non-coverage. A compliance review of your sNCT billing patterns before the effective date is much cheaper than a RAC audit after it. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Sensory Nerve Conduction Threshold Tests Under This Policy
Codes Listed in This Policy Update
This policy update does not list specific CPT, HCPCS Level II, or ICD-10-CM codes. That's not unusual for a CMS modification of this type — code-level specificity typically lives in the MAC LCD rather than the national policy document.
What to Do About the Missing Codes
This is a gap your billing team needs to close before May 15, 2026. Here's how.
Contact your MAC directly and ask which CPT codes are addressed under their current LCD for nerve conduction studies and electrodiagnostic testing. sNCT services have historically been billed under a subset of neurology and electrodiagnostic CPT codes. Your MAC's LCD will tell you exactly which codes are covered, which are non-covered, and what documentation is required for each.
Do not attempt to substitute codes from conventional NCS procedures to "avoid" the sNCT coverage issue. That's upcoding. The clinical service performed must match the code billed, period.
Once your MAC's code list is confirmed, update your charge capture accordingly and make sure your CDM (charge description master) flags sNCT-specific codes for documentation review before claim submission.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.